This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Richard Hall, Executive Vice President, Bob Evans Farms, Inc., Is Appointed As Chairman Of The Board Of Directors Of The Rogosin Institute

NEW YORK, April 10, 2013 /PRNewswire-USNewswire/ -- The Rogosin Institute ("Rogosin" or "The Institute") announces with great pleasure the appointment of Richard Hall, Executive Vice President, Supply Chain, Engineering and Sustainability, Bob Evans Farms, Inc., as Chairman of the Board of Directors effective March 13, 2013.

Hall, closely affiliated with Rogosin since 1994 and a Board member since 2008, brings both a commitment to its vision for healthcare and a breadth of business expertise and experience to The Institute as it continues its path of growth and ever-improving quality of care and research to develop new approaches to treatment.  He succeeds Rogosin's outgoing Board Chair, William Macaulay, Chairman of First Reserve Capital of Greenwich, Connecticut.     

Hall joined the Bob Evans Farms team in 1987 as plant manager at the Xenia, Ohio, facility. Over the past 26 years, he has held ever-increasing levels of responsibility at Bob Evans Farms including Sr. VP of Corporate Procurement and Vice President of Production.  In his current role, he is responsible for all procurement for the company's Food Products and Restaurant divisions, restaurant distribution, transportation, strategic sourcing, facilities purchasing and distribution, livestock procurement and the organization's restaurant engineering and sustainability initiatives.

Rogosin and Bob Evans Farms began a unique relationship in 1994 to advance medical research.  Bob Evans Farms donated laboratory space and an office at their Xenia Plant to Rogosin in an effort to make hog pancreas glands readily available for the advancement of Rogosin's diabetes research program in islet cell macroencapsulation and transplantation for the treatment of Type 1 diabetes. Richard took a personal interest in the project, assisted with all areas of operations, and further encouraged Bob Evans to donate land and help fund the construction of a separate laboratory, opened in 1997.  The research at Rogosin's Xenia Division at Bob Evans Farms has expanded to include research involving a novel approach to the treatment of cancer.

Richard's involvement in assisting the advancement of both the diabetes and cancer research programs continues with tremendous passion and commitment.  "Rogosin is both honored and fortunate to have Richard Hall as its next Board Chair.  His extraordinary leadership and dedication to Rogosin's mission will help guide our growth and success in the years ahead," commented Barry H. Smith, MD, PhD, President and CEO, Rogosin.

"As a long time member of The Rogosin Institute's Board, I've seen the impressive work that's been done by the organization and its members," Hall says. "I look forward to building upon their successes as we continue to expand our operations for kidney dialysis and the treatment of kidney disease as well as bring our research for two of the most devastating diseases - cancer and diabetes – to the patient's bedside.  I can't imagine being engaged in a more rewarding initiative."

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs